Maximus, Inc. (NYSE:MMS) Shares Acquired by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lifted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 722,172 shares of the health services provider's stock after purchasing an additional 16,772 shares during the quarter. Allspring Global Investments Holdings LLC owned about 1.20% of Maximus worth $54,748,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Geode Capital Management LLC grew its position in Maximus by 1.4% during the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock worth $142,109,000 after buying an additional 21,532 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in shares of Maximus by 12.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider's stock worth $86,552,000 after acquiring an additional 102,350 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in shares of Maximus by 277.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider's stock worth $81,878,000 after acquiring an additional 645,760 shares in the last quarter. Reinhart Partners LLC. grew its holdings in shares of Maximus by 43.5% in the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider's stock worth $41,143,000 after acquiring an additional 167,019 shares during the period. Finally, Fort Washington Investment Advisors Inc. OH increased its stake in Maximus by 39.1% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock valued at $22,132,000 after purchasing an additional 83,390 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analyst Ratings Changes

A number of research firms have commented on MMS. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Friday. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd.

Maximus Price Performance

Shares of MMS stock traded up $0.29 during trading hours on Monday, hitting $67.69. The company's stock had a trading volume of 711,566 shares, compared to its average volume of 679,035. The company has a current ratio of 1.72, a quick ratio of 1.49 and a debt-to-equity ratio of 0.82. The business has a fifty day moving average of $74.05 and a 200-day moving average of $82.24. Maximus, Inc. has a twelve month low of $66.52 and a twelve month high of $93.97. The stock has a market cap of $3.87 billion, a price-to-earnings ratio of 14.56 and a beta of 0.72.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.05 EPS for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date is Friday, February 14th. Maximus's dividend payout ratio is presently 25.81%.

Insider Activity at Maximus

In other news, CEO Bruce Caswell purchased 3,500 shares of the stock in a transaction dated Tuesday, December 17th. The stock was acquired at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the acquisition, the chief executive officer now directly owns 275,929 shares in the company, valued at $19,491,624.56. This represents a 1.28 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Raymond B. Ruddy acquired 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the purchase, the director now directly owns 112,520 shares of the company's stock, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 7,063 shares of company stock valued at $502,017. 1.60% of the stock is owned by insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.